Volume 4, Issue 5 pp. 491-497

The prognostic value of the acute-phase response in stroke recurrence

A. Chamorro

Corresponding Author

A. Chamorro

Neurology Service, Hospital Clinic i Provincial, Villaroel 170, 08036 Barcelona, Spain

Neurology Service, Hospital Clinic i Provincial, Villaroel 170, 08036 Barcelona, SpainSearch for more papers by this author
N. Vila

N. Vila

Neurology Service, Hospital Clinic i Provincial, Villaroel 170, 08036 Barcelona, Spain

Search for more papers by this author
R. Blanc

R. Blanc

Neurology Service, Hospital Clinic i Provincial, Villaroel 170, 08036 Barcelona, Spain

Search for more papers by this author
A. Saiz

A. Saiz

Neurology Service, Hospital Clinic i Provincial, Villaroel 170, 08036 Barcelona, Spain

Search for more papers by this author
C. Ascaso

C. Ascaso

Epidemiology and Biostatistics Service of the Department of Medicine, Hospital Clinic i Provincial, Villaroel 170, 08036 Barcelona, Spain

Search for more papers by this author
R. Deulofeu

R. Deulofeu

Department of Clinical Biochemistry, Hospital Clinic i Provincial, Villaroel 170, 08036 Barcelona, Spain

Search for more papers by this author
First published: 20 January 2011
Citations: 6

Abstract

We measured the erythrocyte sedimentation rate (ESR) in 318 acute stroke patients receiving heparin to evaluate its predictor value on the risk of early recurrence (first two weeks). The cumulative risks of early recurrence were 2.93 ± 1.85% for the low ESR group, and 9.77 ± 3.25% for the high ESR group. With logistic regression the risk of early stroke recurrence was associated to the ESR group (OR 3.55, 95% IC 1.24-10.15), and a history of recent (< 1 week) (OR 6.95, 95% IC 2.06–23.42), or remote TIA (OR 4.27, 95% IC 1.22-14.91). These results pointed to an inflammatory component in the pathogenesis of early recurrent stroke.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.